Dynavax to Present at the William Blair 40th Annual Growth Stock Conference
May 28 2020 - 4:05PM
Dynavax Technologies Corporation (Nasdaq: DVAX), a
biopharmaceutical company focused on developing and commercializing
novel vaccines, today announced that Ryan Spencer, Chief Executive
Officer, will participate in a virtual fireside chat at the William
Blair 40th Annual Growth Stock Conference on Tuesday, June 9, at
12:00 p.m. C.T.
The presentation will be webcast and may be
accessed through the “Events & Presentations” page on the
“investors” section of the Company’s website at
http://investors.dynavax.com/events-presentations.
About DynavaxDynavax is a
commercial stage biopharmaceutical company developing and
commercializing novel vaccines. The Company launched its first
commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant),
Adjuvanted], in February 2018, following U.S. FDA approval for
prevention of infection caused by all known subtypes of hepatitis B
virus in adults age 18 years and older. Dynavax is also
advancing CpG 1018 as a premier vaccine adjuvant through research
collaborations and partnerships. For more information, visit
www.dynavax.com and follow the company on LinkedIn.
Contacts:
Nicole Arndtnarndt@dynavax.com510-665-7264
Derek Cole, President Investor Relations Advisory Solutions
derek.cole@IRadvisory.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024